Earnings History Data for Inhibrx Biosciences, Inc. (INBX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Inhibrx Biosciences, Inc.

Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2024	PM		INBX	Inhibrx Biosciences, Inc.	240.00	-2.84	-3.06	0.00	Inhibrx Biosciences GAAP EPS of -$2.84 [11/15/2024 7:00 AM]	13.76	-0.57 (-4.01%)	14.33	0.0 (0.00%)	10.80 - 18.95	171,468	70,000	2,467
Inhibrx Biosciences GAAP EPS of -$2.84 [11/15/2024 7:00 AM] Inhibrx Biosciences Reports Third Quarter 2024 Financial Results [Nov-14-24 04:24PM]
28-02-2024	PM		INBX	Inhibrx	1,830	-1.73	-1.07	0.00		37.00	-2.56 (-6.47%)	0.0	0.0 (0.00%)	14.31 - 39.79	1,141,857	300,000	0

09-11-2023	AH		INBX	Inhibrx	869.00	-1.10	-1.01	0.00		19.11	0.81 (4.43%)	18.30	0.0 (0.00%)	14.31 - 34.72	399,079	390,000	14,157
Inhibrx posts Q3 results [11/10/2023 10:31 AM]
07-08-2023	AH		INBX	Inhibrx	879.00	-1.08	-1.02	0.00		16.94	-2.38 (-12.32%)	19.32	0.0 (0.00%)	12.60 - 34.72	296,117	560,000	4,249

07-11-2022	AH		INBX	Inhibrx	1,255	-0.90	-1.01	0.00	Inhibrx GAAP EPS of -$0.90 beats by $0.04, revenue of $0.28M misses by $0.29M [11/7/2022 5:03 PM]	29.84	0.76 (2.61%)	29.08	0.0 (0.00%)	7.67 - 45.99	398,406	510,000	13,954
Inhibrx GAAP EPS of -$0.90 beats by $0.04, revenue of $0.28M misses by $0.29M [11/7/2022 5:03 PM] Inhibrx Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights [Nov-07-22 04:05PM]
09-05-2022	AH		INBX	Inhibrx	659.00	-0.80	-0.62	0.00	Inhibrx GAAP EPS of -$0.80 misses by $0.20, revenue of $0.93M misses by $0.17M [5/9/2022 5:27 PM]	14.92	0.33 (2.26%)	14.59	0.0 (0.00%)	14.24 - 47.90	453,569	270,036	6,162
Inhibrx GAAP EPS of -$0.80 misses by $0.20, revenue of $0.93M misses by $0.17M [5/9/2022 5:27 PM] Inhibrx Reports First Quarter 2022 Financial Results and Recent Corporate Highlights [May-09-22 04:05PM] Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 05:25PM] Inhibrx, Inc. (INBX) Reports Q1 Loss, Misses Revenue Estimates [May-09-22 06:35PM]
28-02-2022	AH		INBX	Inhibrx	837.00	-0.55	-0.53	0.00	Inhibrx GAAP EPS of -$0.55 beats by $0.02, revenue of $2.86M beats by $1.15M [2/28/2022 5:39 PM]	21.82	0.32 (1.49%)	21.50	0.0 (0.00%)	14.27 - 47.90	125,952	190,000	3,102
Inhibrx GAAP EPS of -$0.55 beats by $0.02, revenue of $2.86M beats by $1.15M [2/28/2022 5:39 PM] Inhibrx Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Recent Corporate Highlights [Feb-28-22 04:05PM]
09-11-2021	AH	4:40 PM ET (Nov 9)	INBX	Inhibrx	1,696	-0.54	-0.57	0.00	Inhibrx EPS beats by $0.03, beats on revenue [11/9/2021 5:07 PM]	43.13	-0.75 (-1.71%)	43.88	0.0 (0.00%)	14.27 - 50.97	126,552	240,000	420
Inhibrx EPS beats by $0.03, beats on revenue [11/9/2021 5:07 PM] Inhibrx Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights [Nov-09-21 04:05PM] Inhibrx, Inc. (INBX) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 06:45PM] Inhibrx (NASDAQ:INBX) pulls back 3.4% this week, but still delivers shareholders impressive 139% return over 1 year [Nov-10-21 07:47AM]
09-08-2021	AH		INBX	Inhibrx, Inc.	1,040	-0.55	-0.51	0.00		29.50	1.55 (5.55%)	0.0	0.0 (0.00%)	14.27 - 50.97	176,382	140,000	0
Inhibrx Reports Second Quarter 2021 Financial Results [Aug-09-21 04:38PM]
13-05-2021	AH	After the close (May 13)	INBX	Inhibrx, Inc.	606.00	-0.51	-0.61	0.00	Inhibrx EPS beats by $0.08, misses on revenue [5/13/2021 5:30 PM]	16.58	-0.24 (-1.43%)	16.82	0.0 (0.00%)	14.27 - 50.97	39,076	120,000	237
Inhibrx EPS beats by $0.08, misses on revenue [5/13/2021 5:30 PM] Inhibrx Reports First Quarter 2021 Financial Results [May-13-21 04:10PM]
12-03-2021	PM		INBX	Inhibrx, Inc.	995.23	-0.47	-0.50	0.00	Inhibrx EPS beats by $0.14, beats on revenue [3/12/2021 9:45 AM]	23.49	-1.62 (-6.45%)	0.0	0.0 (0.00%)	15.20 - 50.97	28,995	134,279	0
Inhibrx EPS beats by $0.14, beats on revenue [3/12/2021 9:45 AM] Inhibrx Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Announces Phase 1 Single Agent Dose Escalation Results for INBRX-105, a Novel Targeted 4-1BB Agonist [Mar-12-21 09:00AM]